首頁 > 市場調查報告書 > 醫療設備

隔膜技術

市場調查報告書

商品編碼

1489498

全球離心機市場 - 2024-2031

Global Centrifuge Market - 2024-2031

出版日期: 2024年06月05日 | 出版商:

DataM Intelligence | 英文 210 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

全球離心機市場在 2023 年達到 101 億美元，預計到 2031 年將達到 144 億美元，在 2024-2031 年預測期間複合年成長率為 4.5%。

各國政府改善藥品監管政策、標準化臨床研究和修改報銷政策的努力正在幫助該產業的發展。此外，越來越多的技術先進的實驗室離心機的推出為實驗室離心機市場在預測期內的發展提供了有利可圖的機會。

新產品的推出經常整合尖端技術創新，如小型化和便攜性、提高速度和加速度、先進的冷卻系統以及與自動化和機器人的整合。例如，2021 年 4 月，久保田公司推出了桌上型離心機 S500T 型和落地式冷凍離心機 S500FR 型。此機型具有創新且安全的控制功能，如「自我檢測功能」、「不平衡早期偵測器」、「混合裝載桶」和「3年保固」。

到 2023 年，北美預計將成為主導地區，佔全球離心機市場的 35% 以上。由於化學工業對該地區離心機市場的貢獻巨大，該市場正在不斷發展。美國化學理事會預計，2022年化工產業全球總銷售額將達5.72兆美元。

動力學

醫療保健診斷的進步

離心是臨床實驗室分離血液成分、尿液沉渣和其他生理液體的重要過程。隨著慢性病和感染的日益流行，可靠、快速的診斷資訊對於最佳的患者護理至關重要。離心機設計技術先進，導致設備具有更快的處理時間、更好的樣品處理能力和更易用性。

此外，將離心機與其他診斷技術（例如流式細胞儀和分子診斷）結合，可以對患者樣本進行徹底和多維的研究。由於醫療保健行業傾向於強調早期疾病識別和個人化治療技術，因此對提高診斷準確性和效率的先進離心機的需求仍然是主要的市場驅動力。

不斷發展的生物技術和藥物研究

這些行業處於創新的中心，不斷尋找新方法來更好地了解疾病、開發新療法和提高醫療保健效果。離心機在這些活動中發揮重要作用，因為它們可以精確分離、隔離和研究眾多生物成分。在生物技術領域，科學家正在研究複雜的生物過程、蛋白質相互作用和遺傳系統。

離心機透過利用離心力根據質量和密度分離物質來滿足這些需求。這對於基因組學、蛋白質組學和分子生物學等領域的研究是必要的，其中分離核酸、蛋白質和細胞器對於深入了解疾病途徑和產生標靶治療至關重要。

高成本和監管

離心機設備的購買成本可能很高，尤其是用於研究、生物技術和製藥應用的高速和專用類型。離心機的高昂初始成本可能會阻止一些實驗室、學術機構和小型企業投資該設備，特別是那些預算緊張或財務拮据的企業。

除了原始支出外，由於能源消耗、維護和試管和轉子等消耗品，運行離心機的成本可能很高。經常性費用可能會對財務造成負擔，特別是對於資源有限的企業。離心機的使用可能受到監管法規的約束，特別是在醫療保健和生物技術領域。遵守標準和法律可能會增加使用者的管理麻煩和費用，從而影響採用和使用。

Government efforts in various nations to improve medicine regulatory policies, standardize clinical research and modify reimbursement policies are helping to expand the industry. Furthermore, the increasing number of technologically advanced laboratory centrifuges being launched presents a profitable opportunity for the laboratory centrifuge market to develop during the forecast period.

New product introductions frequently integrate cutting-edge technological innovations like downsizing & portability, increased speed & acceleration, advanced cooling systems and integration with automation and robots. For example, in April 2021, Kubota Corporation introduced the Benchtop Centrifuge Model S500T and the Floor Standing Refrigerated Centrifuge Model S500FR. The models contain innovative and safe control functions like "Self-Check Function", "Imbalance Early Detector", "Mixed-loading buckets" and "3-year warranty".

In 2023, North America is expected to be the dominant region with over 35% of the global Centrifuge market. The market is developing as the chemical industry contributes significantly to the region's centrifuges market. The American Chemistry Council estimates that the chemical industry's total global sales will be US$ 5.72 trillion in 2022. In 2022, the chemical sector revenue achieved its highest value in the previous 15 years.

Dynamics

Diagnostic Advancements in Healthcare

Centrifugation is an essential process in clinical laboratories for separating blood components, urine sediments and other physiological fluids. With the increasing prevalence of chronic diseases and infections, reliable and fast diagnostic information is critical for optimal patient care. Centrifuge design technology has advanced, resulting in equipment with faster processing times, better sample handling capabilities and more ease of use.

Furthermore, integrating centrifuges with other diagnostic technologies, such as flow cytometry and molecular diagnostics, allows for thorough and multidimensional study of patient samples. As the healthcare industry tends to emphasize early disease identification and individualized treatment techniques, the demand for advanced centrifuges that boost diagnostic accuracy and efficiency remains a major market driver.

Growing Biotechnology and Pharmaceutical Research

The industries are at the centre of innovation, continuously looking for new ways to better understand diseases, develop novel treatments and enhance healthcare outcomes. Centrifuges play an important part in these activities because they allow for the accurate separation, isolation and study of numerous biological components. In the field of biotechnology, scientists are studying complex biological processes, protein interactions and genetic systems.

Centrifuges meet these needs by using centrifugal force to separate substances based on mass and density. It is necessary for research in domains such as genomics, proteomics and molecular biology, where separating nucleic acids, proteins and organelles is vital for gaining insights into disease pathways and generating targeted therapeutics.

High Costs and Regulations

Centrifuge equipment can be costly to purchase, especially high-speed and specialized types used in research, biotechnology and pharmaceutical applications. Centrifuges' high initial cost may dissuade some laboratories, academic institutions and small enterprises from investing in this equipment, especially those with tight budgets or financial constraints.

Aside from the original expenditure, operating centrifuges can be costly due to energy consumption, maintenance and consumables such as tubes and rotors. The recurring expense might put a burden on finances, especially in businesses with limited resources. Centrifuge use may be subject to regulatory regulations, especially in healthcare and biotechnology. Compliance with standards and laws can increase administrative hassles and expenses for users, affecting adoption and use.

Segment Analysis

The global centrifuge market is segmented based on product, model, rotor design, operation mode, end-user and region.

Rising Demand of Chemicals Drives the Segment Growth

Biotechnology & pharmaceutical is expected to be the dominant segment with over 30% of the market during the forecast period 2024-2031. As chemical processing capacity increases, there is a greater demand for separation and purification technologies such as centrifuges to handle bigger volumes of chemicals while maintaining product quality and purity. As a result, centrifuge producers will benefit from increased prospects in the globally chemical industry.

Rising global demand for chemicals in a variety of industries, including pharmaceuticals and biotechnology, is driving infrastructure investments to satisfy growing production demands. For example, in September 2023, Sichuan Hebang Biotechnology Co. declared an investment of US$ 800 million to build a chemical production facility at the Java Integrated Industrial and Port Estate. Upon completed, the facility will have a yearly output of 600,000 tons of sodium carbonate and ammonium chloride, with a glyphosate production capacity estimated to be 200,000 tons.

Geographical Penetration

Rising Demand from Various End-User Industries in Asia-Pacific

Asia-Pacific is expected to be t he fastest growing region in the global centrifuge market covering over 20% of the market. Asia-Pacific is one of the fastest expanding centrifuge markets, owing to China's dominance in the chemical and industrial, pharmaceutical and wastewater treatment industries. Furthermore, nations such as India, Indonesia and Malaysia are experiencing tremendous growth in energy demand as a result of increased industrial activity.

China's National Energy Administration is considering boosting the scope of the country's clean energy programs this decade. The NEA recommends that China obtain 40% of its electricity through nuclear and renewable sources by 2031, with a nuclear capacity target of 120-150 gigawatts by 2031. Such government policies and aims assist the nation's growth of nuclear power plants in the coming years and are expected to generate chances for the centrifuges industry.

Competitive Landscape

The major global players in the market include Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Sartorius AG, Eppendorf AG, QIAGEN, Kubota Corporation, NuAire, Sigma Laborzentrifugen GmbH and Andreas Hettich GmbH & Co. KG.

COVID-19 Impact Analysis

The pandemic impacted globally supply networks, including centrifuge manufacturing. Movement restrictions, border closures and lockdown procedures caused delays in the transit of raw materials, components and final products. The caused supply shortages and production delays for centrifuge producers, limiting their capacity to meet client demand. The epidemic caused interruptions or slowdowns in several businesses that use centrifuges, including academic research, biotechnology and pharmaceuticals.

Research facilities were temporarily stopped, clinical studies were delayed and non-essential medical procedures were rescheduled, resulting in lower demand for centrifuges in these industries. The pandemic-induced economic slowdown has had an impact on government funding for research programs and academic institutions. Budget cuts and resource reallocation resulted in lower investment on research equipment, such as centrifuges. The impacted centrifuge sales to research institutions and universities.

Russia-Ukraine War Impact

Russia and Ukraine are major suppliers of raw materials, components and machinery for centrifuge manufacturing. Any production or shipping problems caused by the conflict resulted in supply shortages or delays in the globally centrifuge market. It impacted the supply of centrifuge components, spare parts and equipment, disrupting global manufacturing operations and delivery timelines.

The dispute between Russia and Ukraine has globally consequences, including the oil, gas and nuclear energy industries. Centrifuges are employed in a variety of energy-related activities, including as oil and gas drilling, refining and nuclear power generation. Changes in energy supply chains or changes in energy regulations stemming from the conflict affected demand for centrifuges and related equipment.

By Product

Equipment
- Multipurpose Centrifuge
- Microcentrifuges
- Ultracentrifuges
- Others
Accessories
- Rotors
- Tubes
- Buckets
- Others

By Model

Benchtop
Floor-Standing

By Rotor Design

Fixed-angle
Swinging-Bucket
Vertical
Others

By Operation Mode

Batch
Continuous

By End-User

Hospitals & Blood Banks
- Clinical
- Research
- Others
Biotechnology & Pharmaceutical
- Clinical
- Research
- Biotherapeutic Manufacturing
- Others
Oil and Petroleum
Chemicals
Food & Beverages
Water and Wastewater Treatment
Metal & Mining
Power
Pulp & Paper
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In January 2024, GEA launched X Control, a new centrifuge control system. The introduction of X Control paves the way for the integration of Artificial Intelligence, which promises faster and simpler data collecting and analysis, as well as self-optimization of the entire system in the future. Increased processing capabilities will also improve collaboration with Supervisory Control and Data Acquisition systems.
In September 2023, U.S. Army Engineer Research and Development Center conducted an overhaul of beam centrifuges, modernizing one of the most inventive pieces of technology. The centrifuge in the Geotechnical and Structures Laboratory's Geotechnical Engineering and Geosciences Branch has been upgraded with enhancements to its electrical and hydraulic systems and extensive renovations to the control building.

Why Purchase the Report?

To visualize the global centrifuge market segmentation based on product, model, rotor design, operation mode, end-user and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of centrifuge market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global centrifuge market report would provide approximately 78 tables, 77 figures and 210 pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1.Methodology and Scope

1.1.Research Methodology
1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

3.1.Snippet by Product
3.2.Snippet by Model
3.3.Snippet by Rotor Design
3.4.Snippet by Operation Mode
3.5.Snippet by End-User
3.6.Snippet by Region

4.Dynamics

4.1.Impacting Factors
- 4.1.1.Drivers
  - 4.1.1.1.Diagnostic Advancements in Healthcare
  - 4.1.1.2.Growing Biotechnology and Pharmaceutical Research
- 4.1.2.Restraints
  - 4.1.2.1.High Costs and Regulations
- 4.1.3.Opportunity
- 4.1.4.Impact Analysis

5.Industry Analysis

5.1.Porter's Five Force Analysis
5.2.Supply Chain Analysis
5.3.Pricing Analysis
5.4.Regulatory Analysis
5.5.Russia-Ukraine War Impact Analysis
5.6.DMI Opinion

6.COVID-19 Analysis

6.1.Analysis of COVID-19
- 6.1.1.Scenario Before COVID-19
- 6.1.2.Scenario During COVID-19
- 6.1.3.Scenario Post COVID-19
6.2.Pricing Dynamics Amid COVID-19
6.3.Demand-Supply Spectrum
6.4.Government Initiatives Related to the Market During Pandemic
6.5.Manufacturers Strategic Initiatives
6.6.Conclusion

7.By Product

7.1.Introduction
- 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2.Market Attractiveness Index, By Product
7.2.Equipment*
- 7.2.1.Introduction
- 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.2.3.Multipurpose Centrifuge
- 7.2.4.Microcentrifuges
- 7.2.5.Ultracentrifuges
- 7.2.6.Others
7.3.Accessories
- 7.3.1.Rotors
- 7.3.2.Tubes
- 7.3.3.Buckets
- 7.3.4.Others

8.By Model

8.1.Introduction
- 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Model
- 8.1.2.Market Attractiveness Index, By Model
8.2.Benchtop*
- 8.2.1.Introduction
- 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3.Floor-Standing

9.By Rotor Design

9.1.Introduction
- 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Rotor Design
- 9.1.2.Market Attractiveness Index, By Rotor Design
9.2.Fixed-angle*
- 9.2.1.Introduction
- 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3.Swinging-Bucket
9.4.Vertical
9.5.Others

10.Operation Mode

10.1.Introduction
- 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Mode
- 10.1.2.Market Attractiveness Index, By Operation Mode
10.2.Batch*
- 10.2.1.Introduction
- 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3.Continuous

11.End-User

11.1.Introduction
- 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.1.2.Market Attractiveness Index, By End-User
11.2.Hospitals & Blood Banks*
- 11.2.1.Introduction
- 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
- 11.2.3.Clinical
- 11.2.4.Research
- 11.2.5.Others
11.3.Biotechnology & Pharmaceutical
- 11.3.1.Clinical
- 11.3.2.Research
- 11.3.3.Biotherapeutic Manufacturing
- 11.3.4.Others
11.4.Oil and Petroleum
11.5.Chemicals
11.6.Food & Beverages
11.7.Water and Wastewater Treatment
11.8.Metal & Mining
11.9.Power
11.10.Pulp & Paper
11.11.Others

12.By Region

12.1.Introduction
- 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 12.1.2.Market Attractiveness Index, By Region
12.2.North America
- 12.2.1.Introduction
- 12.2.2.Key Region-Specific Dynamics
- 12.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 12.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Model
- 12.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Rotor Design
- 12.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Mode
- 12.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.2.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.2.8.1.U.S.
  - 12.2.8.2.Canada
  - 12.2.8.3.Mexico
12.3.Europe
- 12.3.1.Introduction
- 12.3.2.Key Region-Specific Dynamics
- 12.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 12.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Model
- 12.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Rotor Design
- 12.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Mode
- 12.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.3.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.3.8.1.Germany
  - 12.3.8.2.UK
  - 12.3.8.3.France
  - 12.3.8.4.Italy
  - 12.3.8.5.Russia
  - 12.3.8.6.Rest of Europe
12.4.South America
- 12.4.1.Introduction
- 12.4.2.Key Region-Specific Dynamics
- 12.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 12.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Model
- 12.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Rotor Design
- 12.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Mode
- 12.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.4.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.4.8.1.Brazil
  - 12.4.8.2.Argentina
  - 12.4.8.3.Rest of South America
12.5.Asia-Pacific
- 12.5.1.Introduction
- 12.5.2.Key Region-Specific Dynamics
- 12.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 12.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Model
- 12.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Rotor Design
- 12.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Mode
- 12.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.5.8.1.China
  - 12.5.8.2.India
  - 12.5.8.3.Japan
  - 12.5.8.4.Australia
  - 12.5.8.5.Rest of Asia-Pacific
12.6.Middle East and Africa
- 12.6.1.Introduction
- 12.6.2.Key Region-Specific Dynamics
- 12.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 12.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Model
- 12.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Rotor Design
- 12.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Mode
- 12.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13.Competitive Landscape

13.1.Competitive Scenario
13.2.Market Positioning/Share Analysis
13.3.Mergers and Acquisitions Analysis

14.Company Profiles

14.1.Thermo Fisher Scientific Inc.*
- 14.1.1.Company Overview
- 14.1.2.Product Portfolio and Description
- 14.1.3.Financial Overview
- 14.1.4.Key Developments
14.2.Danaher Corporation
14.3.Becton, Dickinson and Company
14.4.Sartorius AG
14.5.Eppendorf AG
14.6.QIAGEN
14.7.Kubota Corporation
14.8.NuAire
14.9.Sigma Laborzentrifugen GmbH
14.10.Andreas Hettich GmbH & Co. KG

LIST NOT EXHAUSTIVE